Board meeting on Nov 4 to consider Q2 FY26-27 results

Results View source PDF Explain this filing

MAKERSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.3%Reaction day

₹209.00

prior close

₹200.39

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-2.7% vs market

Pharmaceuticals peers, median of 172sector-1.7%-3.6% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 3.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.8

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.3-2.6-2.7-1.7-3.6

Next day

-4.7-3.6-1.1-2.1-2.6

-10.5-5.8-4.7-3.4-7.1

-11.3-5.5-5.9-2.3-9.0

-10.5-3.8-6.7-1.1-9.4

-10.0pendingpending+0.2-10.2

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Makers Laboratories has informed BSE that its Board of Directors will meet on 4th November 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended 30th September 2026. The trading window for insiders is closed from 1st October 2026 until 48 hours after results are declared, that is till 6th November 2026.

Likely market impact

Routine pre-results notice. Investors should expect Q2 FY26-27 earnings on or around 6th November 2026; no new information today.